Both David Brennan of AstraZeneca and Andrew Witty of GlaxoSmithKline have now come out publicly against mega-mergers. Mr Witty has gone a step further.

GSK says its spin-off of HIV medicines into a company controlled jointly with Pfizer is "innovative". That remains to be seen.